HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular modeling of lanthionine synthetase component C-like protein 2: a potential target for the discovery of novel type 2 diabetes prophylactics and therapeutics.

Abstract
The rates of type 2 diabetes (T2D) are rising to epidemic proportions in the US and worldwide. While current T2D medications are efficacious, significant side effects have limited their use and availability. Our laboratory has discovered that abscisic acid (ABA) exerts anti-diabetic effects, in part, by activating peroxisome proliferator-activated receptor γ (PPAR γ). However, since ABA does not bind to the ligand-binding domain (LBD) of PPAR γ, the mechanism of activation of PPAR γ by ABA remains unknown. Lanthionine synthetase component C-like protein 2 (LANCL2) was predicted to be a novel target for the binding and signaling of ABA in human granulocytes and rat insulinoma cells. The goal of this study was to determine whether LANCL2 is a molecular target of ABA and other PPAR γ agonists. To this end we performed homology modeling to construct a three-dimensional structure of LANCL2 using the crystal structure of LANCL1 as a template. Our molecular docking studies predicted that ABA and other PPAR γ agonists (e.g., rosiglitazone and pioglitazone) share a binding site on the surface of LANCL2. The identification of a binding site for PPAR γ agonists will facilitate the high-throughput virtual screening of large compound libraries and may shed new light on alternative mechanisms of PPAR γ activation.
AuthorsPinyi Lu, David R Bevan, Stephanie N Lewis, Raquel Hontecillas, Josep Bassaganya-Riera
JournalJournal of molecular modeling (J Mol Model) Vol. 17 Issue 3 Pg. 543-53 (Mar 2011) ISSN: 0948-5023 [Electronic] Germany
PMID20512604 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Hypoglycemic Agents
  • LANCL1 protein, human
  • LANCL2 protein, human
  • Ligands
  • Membrane Proteins
  • Nuclear Proteins
  • PPAR gamma
  • Phosphate-Binding Proteins
  • Receptors, G-Protein-Coupled
  • Abscisic Acid
Topics
  • Abscisic Acid (chemistry, metabolism)
  • Amino Acid Sequence
  • Binding Sites
  • Conserved Sequence
  • Crystallography, X-Ray
  • Diabetes Mellitus, Type 2 (drug therapy, prevention & control)
  • Humans
  • Hypoglycemic Agents (chemistry)
  • Ligands
  • Membrane Proteins (chemistry)
  • Models, Molecular
  • Molecular Sequence Data
  • Nuclear Proteins (chemistry)
  • PPAR gamma (agonists, chemistry, metabolism)
  • Phosphate-Binding Proteins
  • Protein Structure, Tertiary
  • Receptors, G-Protein-Coupled (chemistry)
  • Sequence Alignment
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: